Development and testing of solid dose formulations containing polysialic acid insulin conjugate: Next generation of long-acting insulin

Journal of Diabetes Science and Technology

Volumn 4, Issue 3, 2010, Pages 532-539

  Zhang, Rongsheng ^a   Jain, Sanjay ^a   Rowland, Martin ^b   Hussain, Nasir ^b   Agarwal, Mohak ^a   Gregoriadis, Gregory ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b Glide Pharmaceutical Technologies Limited   (United Kingdom)

Author keywords

Colominic acid; Diabetes; Needle free injection; Polysialic acid; Polysialic acid insulin; Solid dose injector; SuliXen

Indexed keywords

ANTIDIABETIC AGENT; LONG ACTING INSULIN; POLYSIALIC ACID; SIALIC ACID DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG DOSAGE FORM; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; INSTRUMENTATION; METHODOLOGY; RAT; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYNTHESIS;

ANIMALS; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN, LONG-ACTING; RATS; RATS, SPRAGUE-DAWLEY; SIALIC ACIDS;

EID: 78349292302     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400305     Document Type: Conference Paper

References (20)

1. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003;2(3):214-21. (Pubitemid 37361666)
2. Vincent MJ, Ringsdorf H, Duncan R. Polymer therapeutics: clinical applications and challenges for development. Adv Drug Deliv Rev. 2009;61(13):1117-20.
3. Hoffman AS. The origins and evolution of "controlled" drug delivery systems. J Control Release. 2008;132(3):153-63.
4. Mehvar R. Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation. J Pharm Pharm Sci. 2000;3(1):125-36.
5. Caliceti P, Veronese FM. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev. 2003;55(10):1261-77. (Pubitemid 37464561)
6. Veronese FM. PEGylated proteins: an updated review. Presented at AAPS Meeting and Exposition, Los Angeles, CA. November 8-12, 2009.
7. Gregoriadis G, McCormack B, Wang Z, Lifely R. Polysialic acids: potential in drug delivery. FEBS Lett. 1993;315(3):271-6. (Pubitemid 23025022)
8. Gregoriadis G, Fernandes A, Mital M, McCormack B. Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics. Cell Mol Life Sci. 2000;57(13-14):1964-9. (Pubitemid 32102590)
9. Fernandes AI, Gregoriadis G. Polysialylated asparaginse: preparation, activity and pharmacokinetics. Biochim Biophys Acta. 1997;1341(1):26-34. (Pubitemid 27357031)
10. Fernandes AI, Gregoriadis G. Synthesis, characterization and properties of polysialylated catalase. Biochim Biophys Acta. 1996;1293(1):92-6.
11. Constantinou A, Epenetos AA, Hreczuk-Hirst D, Jain S, Deonarain MP. Modulation of antibody pharmacokinetics by chemical polysialylation. Bioconjug Chem. 2008;19(3):643-50. (Pubitemid 351431395)
12. Jain S, Hreczuk-Hirst D, McCormack B, Mital M, Epenetos A, Laing P, Gregoriadis G. Polysialylated insulin: synthesis, characterization and biological activity in vivo. Biochim Biophys Acta. 2003;1622(1):42-9. (Pubitemid 36776349)
13. Constantinou A, Epenetos AA, Hreczuk-Hirst D, Jain S, Wright M, Chester KA, Deonarain MP. Site-specific polysialylation of an antitumor single-chain Fv fragment. Bioconjug Chem. 2009;20(5):924-31.
14. Gregoriadis G, Jain S, Papaioannou I, Laing P. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids. Int J Pharm. 2005;300(1-2):125-30. (Pubitemid 41112174)
15. Jain S, Hreczuk-Hirst D, Laing P, Gregoriadis G. Polysialylation: the natural way to improve the stability and pharmacokinetics of protein and peptide drugs. Drug Deliv Sys Sci. 2004;4(1):3-9.
16. Florence AT, Hillery AM, Hussain N, Jani PU. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Rel. 1995;36(1-2):39-46.
17. Shergold OA, Fleck NA. Experimental investigation into the deep penetration of soft solids by sharp and blunt punches, with application to the piercing of skin. J Biomech Eng. 2005;127(5):838-48. (Pubitemid 41374644)
18. Bennett S, Potter C. Solid dose injection of therapeutics and vaccines: effective, convenient and cost-effective alternative to needles. In: Delivering injectables: formulations, auto-injectors and needle-free. East Sussex: ONdrugDelivery; 2008, 11-3.
19. Bolli GB. Initiation of insulin treatment in type 2 diabetes mellitus. Eur Endo Dis. 2007;1:40-1.
20. Harrism G, Diment A, Sulway M, Wilkinson M. Glucagon administration underevaluated and undertaught. Pract Diab Int. 2001;18(1):22-5.